Appendix B: Guideline review panel
The Guideline Review Panel is an independent panel that oversees the development of the guideline and takes responsibility for monitoring adherence to NICE guideline development processes. In particular, the panel ensures that stakeholder comments have been adequately considered and responded to. The panel includes members from the following perspectives: primary care, secondary care, lay, public health and industry.
General Practitioner, Workington (Chair)
Head of Medical Affairs, Novartis Pharmaceuticals UK Ltd
Clinical Governance and Prescribing Lead and General Practitioner, North Tees Primary Care Trust